Page last updated: 2024-08-24

darglitazone and Diabetes Mellitus, Type 2

darglitazone has been researched along with Diabetes Mellitus, Type 2 in 3 studies

*Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. [MeSH]

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clark, DA; Dambek, PJ; Goldstein, SW; Hulin, B; Kappeler, WH; Lamphere, CH; Lewis, DM; McDermott, RE; Rizzi, JP1
Cabré, A; Camejo, G; Hultén, LM; Norén, K; Pedreño, J; Svensson, L; Vallvé, JC; Wiklund, O1
Boden, G; Chaiken, RL; Eckert-Norton, M; Gelfand, RA; Lebovitz, HE; Pasmantier, R; Ryan, I1

Trials

1 trial(s) available for darglitazone and Diabetes Mellitus, Type 2

ArticleYear
Metabolic effects of darglitazone, an insulin sensitizer, in NIDDM subjects.
    Diabetologia, 1995, Volume: 38, Issue:11

    Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Obesity; Thiazoles; Thiazolidinediones

1995

Other Studies

2 other study(ies) available for darglitazone and Diabetes Mellitus, Type 2

ArticleYear
Novel thiazolidine-2,4-diones as potent euglycemic agents.
    Journal of medicinal chemistry, 1992, May-15, Volume: 35, Issue:10

    Topics: Alcohols; Animals; Benzopyrans; Blood Glucose; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Ketones; Mice; Mice, Inbred C57BL; Thiazoles; Thiazolidinediones

1992
Fatty acids modulate the effect of darglitazone on macrophage CD36 expression.
    European journal of clinical investigation, 2003, Volume: 33, Issue:6

    Topics: Arteriosclerosis; CD36 Antigens; Diabetes Mellitus, Type 2; Fatty Acids; Humans; Macrophages; Receptors, Immunologic; Receptors, Scavenger; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Thiazolidinediones

2003